| Clark Jackson, | |
|
2500 S 60th St Apt 21, Lincoln, NE 68506-3579 | |
| (402) 613-2633 | |
| Not Available |
| Full Name | Clark Jackson |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 2500 S 60th St Apt 21, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053768945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 70693 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Of Nebraska Llc | 2264857135 | 23 |
| The Urology Center, Pc | 2961396833 | 18 |
| Mid Plains Anesthesia, Llc | 6800214297 | 3 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Memorial Community Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265408819 PECOS PAC ID: 0749190775 Enrollment ID: O20040202001065 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | The Urology Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114919875 PECOS PAC ID: 2961396833 Enrollment ID: O20040614001603 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | St Marys Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528016995 PECOS PAC ID: 7113831926 Enrollment ID: O20071128000886 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Metro Omaha Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558884072 PECOS PAC ID: 1456626050 Enrollment ID: O20171009000112 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Chi Health Clinic Physician Enterprise-anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356858419 PECOS PAC ID: 2264794569 Enrollment ID: O20180404000022 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Orthoanesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184265274 PECOS PAC ID: 2860826443 Enrollment ID: O20200107003507 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Of Nebraska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578187670 PECOS PAC ID: 2264857135 Enrollment ID: O20200810001420 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Entity Name | Mid Plains Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710500541 PECOS PAC ID: 6800214297 Enrollment ID: O20200917000179 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clark Jackson, 2500 S 60th St Apt 21, Lincoln, NE 68506-3579 Ph: (402) 613-2633 | Clark Jackson, 2500 S 60th St Apt 21, Lincoln, NE 68506-3579 Ph: (402) 613-2633 |
News Archive
AmeriCann, Inc., a company that develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs, has partnered with local medical marijuana applicants in the state of Illinois.
Researchers report that concurrent use of a custom-made knee brace and foot orthotic produces greater reductions in pathologic knee adduction in patients with knee osteoarthritis than knee- or foot-support alone.
Researchers at Ruhr-Universität Bochum have studied the role of the immune response in the development of glaucoma in mice.
Champions Biotechnology, Inc., an oncology drug development company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced that a Master Service Agreement with Teva Pharmaceutical Industries has been commissioned for the testing of a novel anti-angiogenic compound in the Champions Tumorgraft™ platform.
› Verified 5 days ago
Matthew C. Oliver, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6911 Van Dorn St Ste 2, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 | |
Eric Johnson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2900 S 70th Street, Suite # 450, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 | |
Hillary Marie Bonin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 575 S 70th St Ste 305, Lincoln, NE 68510 Phone: 402-434-5600 Fax: 402-434-5601 | |
Priscilla Boyer, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 575 S 70th St Ste 305, Lincoln, NE 68510 Phone: 402-434-5600 Fax: 402-434-5601 | |
Carl C Blackwood, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5701 Lillibridge St Apt 10, Lincoln, NE 68506 Phone: 607-349-9774 | |
Bridget L Hannon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2900 S 70th St Ste 250, Lincoln, NE 68506 Phone: 402-489-4186 Fax: 402-489-5279 |